Table 1 Demographic information.
No | Age | FXP concentration (pM) | ||||||
|---|---|---|---|---|---|---|---|---|
Average | SD | Range | Average | Median | SD | Range | ||
Male | 101 | 19.2 | 15.3 | 0.3–61.6 | 10.2 | 1.7 | 13.4 | 0.0–43.2 |
Typically developing controls | 24 | 26.0 | 14.9 | 5.5–60.1 | 28.9 | 27.5 | 6.4 | 18.1–43.2 |
Premutation carriers | 7 | 31.1 | 23.4 | 2.2–61.6 | 30.5 | 26.1 | 7.9 | 22.6–42.1 |
Fragile X Syndrome | 70 | 15.7 | 13.2 | 0.3–45.7 | 1.7 | 0.5 | 2.6 | 0.0–10.3 |
Nonmosaic | 36 | 18.2 | 14.6 | 0.3–45.7 | 0.6 | 0.3 | 1.2 | 0.0–6.2 |
Mosaic | 18 | 14.8 | 13.8 | 0.5–41.5 | 3.8 | 2.6 | 3.2 | 0.0–10.3 |
Female | 86 | 33.2 | 18.9 | 0.2–78.4 | 26.4 | 24.8 | 10.6 | 3.1–64.9 |
Typically developing controls | 11 | 20.9 | 18.9 | 0.2–63.8 | 31.6 | 27.5 | 13.7 | 16.1–64.9 |
Premutation carriers | 42 | 47.3 | 13.2 | 9.0–78.4 | 30.1 | 28.5 | 9.6 | 11.8–55.2 |
Fragile X Syndrome | 33 | 19.4 | 10.3 | 1.2–42.9 | 19.9 | 20.9 | 7.1 | 3.1–33.8 |
Methylation mosaicism | 9 | 16.4 | 7.8 | 1.2–25.2 | 22.0 | 20.9 | 7.7 | 9.3–30.6 |
